vs
Gossamer Bio, Inc.（GOSS）与Laird Superfood, Inc.（LSF）财务数据对比。点击上方公司名可切换其他公司
Gossamer Bio, Inc.的季度营收约是Laird Superfood, Inc.的1.0倍（$13.8M vs $13.3M），Laird Superfood, Inc.净利率更高（-13.2% vs -342.3%，领先329.2%），Gossamer Bio, Inc.同比增速更快（47.1% vs 15.0%）
Gossamer Bio是一家临床阶段生物制药企业，专注于发现、开发和商业化用于治疗免疫、炎症和肿瘤领域重症疾病的创新疗法，推进多条自研候选药物管线进入不同临床阶段，主要面向北美及全球其他地区的医疗市场。
Laird Superfood是一家主营植物基功能性超级食品的企业，产品涵盖精品咖啡奶精、补水混合饮品、营养补充剂、植物能量零食等，面向健康意识较强的消费群体，主要在北美市场通过电商及线下零售渠道销售，主打可持续采购的清洁配方。
GOSS vs LSF — 直观对比
营收规模更大
GOSS
是对方的1.0倍
$13.3M
营收增速更快
GOSS
高出32.1%
15.0%
净利率更高
LSF
高出329.2%
-342.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.8M | $13.3M |
| 净利润 | $-47.2M | $-1.8M |
| 毛利率 | — | 34.1% |
| 营业利润率 | -333.6% | -13.5% |
| 净利率 | -342.3% | -13.2% |
| 营收同比 | 47.1% | 15.0% |
| 净利润同比 | -43.0% | -341.4% |
| 每股收益（稀释后） | $-0.21 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GOSSLSF
| Q4 25 | $13.8M | $13.3M | ||
| Q3 25 | $13.3M | $12.9M | ||
| Q2 25 | — | $12.0M | ||
| Q1 25 | — | $11.7M | ||
| Q4 24 | — | $11.6M | ||
| Q3 24 | — | $11.8M | ||
| Q2 24 | $95.8M | $10.0M | ||
| Q1 24 | $0 | $9.9M |
净利润GOSSLSF
| Q4 25 | $-47.2M | $-1.8M | ||
| Q3 25 | $-48.2M | $-975.1K | ||
| Q2 25 | — | $-362.2K | ||
| Q1 25 | — | $-156.2K | ||
| Q4 24 | — | $-398.4K | ||
| Q3 24 | — | $-166.1K | ||
| Q2 24 | $49.2M | $-239.1K | ||
| Q1 24 | $-41.9M | $-1.0M |
毛利率GOSSLSF
| Q4 25 | — | 34.1% | ||
| Q3 25 | — | 36.5% | ||
| Q2 25 | — | 39.9% | ||
| Q1 25 | — | 41.9% | ||
| Q4 24 | — | 38.6% | ||
| Q3 24 | — | 43.0% | ||
| Q2 24 | — | 41.8% | ||
| Q1 24 | — | 40.0% |
营业利润率GOSSLSF
| Q4 25 | -333.6% | -13.5% | ||
| Q3 25 | -369.4% | -7.7% | ||
| Q2 25 | — | -3.3% | ||
| Q1 25 | — | -1.9% | ||
| Q4 24 | — | -4.1% | ||
| Q3 24 | — | -2.3% | ||
| Q2 24 | 54.3% | -3.4% | ||
| Q1 24 | — | -11.0% |
净利率GOSSLSF
| Q4 25 | -342.3% | -13.2% | ||
| Q3 25 | -362.7% | -7.6% | ||
| Q2 25 | — | -3.0% | ||
| Q1 25 | — | -1.3% | ||
| Q4 24 | — | -3.4% | ||
| Q3 24 | — | -1.4% | ||
| Q2 24 | 51.4% | -2.4% | ||
| Q1 24 | — | -10.3% |
每股收益（稀释后）GOSSLSF
| Q4 25 | $-0.21 | — | ||
| Q3 25 | $-0.21 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $0.22 | — | ||
| Q1 24 | $-0.19 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $136.9M | $5.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-122.8M | $11.5M |
| 总资产 | $172.2M | $19.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GOSSLSF
| Q4 25 | $136.9M | $5.1M | ||
| Q3 25 | $180.2M | $5.1M | ||
| Q2 25 | — | $3.9M | ||
| Q1 25 | — | $7.0M | ||
| Q4 24 | — | $8.3M | ||
| Q3 24 | — | $7.9M | ||
| Q2 24 | $354.5M | $7.6M | ||
| Q1 24 | $244.4M | $7.1M |
股东权益GOSSLSF
| Q4 25 | $-122.8M | $11.5M | ||
| Q3 25 | $-82.3M | $12.8M | ||
| Q2 25 | — | $13.4M | ||
| Q1 25 | — | $13.3M | ||
| Q4 24 | — | $13.2M | ||
| Q3 24 | — | $13.1M | ||
| Q2 24 | $81.5M | $12.6M | ||
| Q1 24 | $26.7M | $12.7M |
总资产GOSSLSF
| Q4 25 | $172.2M | $19.2M | ||
| Q3 25 | $208.8M | $18.9M | ||
| Q2 25 | — | $20.4M | ||
| Q1 25 | — | $21.5M | ||
| Q4 24 | — | $19.3M | ||
| Q3 24 | — | $18.8M | ||
| Q2 24 | $373.4M | $18.0M | ||
| Q1 24 | $259.4M | $17.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-48.3M | $68.4K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流GOSSLSF
| Q4 25 | $-48.3M | $68.4K | ||
| Q3 25 | $-36.2M | $1.2M | ||
| Q2 25 | — | $-2.8M | ||
| Q1 25 | — | $-1.3M | ||
| Q4 24 | — | $339.2K | ||
| Q3 24 | — | $305.8K | ||
| Q2 24 | $116.3M | $642.7K | ||
| Q1 24 | $-52.3M | $-422.3K |
资本支出强度GOSSLSF
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | — | — |
现金转化率GOSSLSF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.36× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GOSS
暂无分部数据
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
